Cargando…

Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease

INTRODUCTION: Fecal calprotectin (FC) is a noninvasive tool for examining response to biologics in inflammatory bowel disease (IBD), but its performance in relation to other novel fecal markers of various cellular origins is unknown. METHODS: We performed a prospective multicenter cohort study and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling Lundström, Maria, Peterson, Christer, Lampinen, Maria, Hedin, Charlotte R. H., Keita, Åsa V., Kruse, Robert, Magnusson, Maria K., Lindqvist, Carl Mårten, Repsilber, Dirk, D'Amato, Mauro, Hjortswang, Henrik, Strid, Hans, Rönnblom, Anders, Söderholm, Johan D., Öhman, Lena, Venge, Per, Halfvarson, Jonas, Carlson, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462075/ https://www.ncbi.nlm.nih.gov/pubmed/37256716 http://dx.doi.org/10.14309/ctg.0000000000000605

Ejemplares similares

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles
por: Andersson, Erik, et al.
Publicado: (2017)

Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids
por: Mattsson, Gustav, et al.
Publicado: (2017)

Gut Barrier Dysfunction—A Primary Defect in Twins with Crohn’s Disease Predominantly Caused by Genetic Predisposition
por: Keita, Åsa V, et al.
Publicado: (2018)

Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register
por: Thunberg, Joel, et al.
Publicado: (2022)

Patients with allergic rhinitis and allergic asthma share the same pattern of eosinophil and neutrophil degranulation after allergen challenge
por: Kämpe, Mary, et al.
Publicado: (2011)

Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health
por: Katinios, Georgios, et al.
Publicado: (2020)

Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease
por: Juzenas, Simonas, et al.
Publicado: (2022)

Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress?
por: Ganda Mall, John-Peter, et al.
Publicado: (2018)

The history of genetics in inflammatory bowel disease
por: Ek, Weronica E., et al.
Publicado: (2014)

Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study
por: Jönsson, Ulla-Britt, et al.
Publicado: (2010)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
por: Basyigit, Ilknur, et al.
Publicado: (2004)

Phylogenetic microbiota profiling in fecal samples depends on combination of sequencing depth and choice of NGS analysis method
por: Rajan, Sukithar K., et al.
Publicado: (2019)

Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
por: Öhman, Lena, et al.
Publicado: (2021)

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series
por: Menzella, Francesco, et al.
Publicado: (2021)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2020)

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease
por: Strömbeck, Anna, et al.
Publicado: (2020)

Crohn’s Disease Is Associated With Activation of Circulating Innate Lymphoid Cells
por: Mazzurana, Luca, et al.
Publicado: (2020)

Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During Remission
por: Maasfeh, Lujain, et al.
Publicado: (2021)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Kent, Brian D., et al.
Publicado: (2020)

Corticosteroid treatment reduces headache in eosinophilic meningitis: a systematic review
por: Khamsai, Sittichai, et al.
Publicado: (2021)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
por: Ueno, Masanobu, et al.
Publicado: (2021)

Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
por: Tanabe, Katsuyuki, et al.
Publicado: (2021)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
por: Gong, Yaya, et al.
Publicado: (2022)

Predictive factors for relapse in corticosteroid-treated patients with chronic eosinophilic pneumonia
por: Takeuchi, Naoko, et al.
Publicado: (2022)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids
por: Holst, Luiza Moraes, et al.
Publicado: (2022)

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study
por: Visuri, Isabella, et al.
Publicado: (2023)

The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study
por: Holster, Savanne, et al.
Publicado: (2019)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
por: Cheng, Shih-Lung
Publicado: (2018)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Omalizumab Restores Response to Corticosteroids in Patients with Eosinophilic Chronic Rhinosinusitis and Severe Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2021)

Validation of Epigenetic Markers for the Prediction of Response to Topical Corticosteroid Treatment in Eosinophilic Esophagitis
por: Jensen, Elizabeth T., et al.
Publicado: (2023)

Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
por: Misaki, Yumiko, et al.
Publicado: (2023)

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms
por: Moraes, Luiza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4bhphrl11kmunkipcrkuagd2id